- Home
- WAFD vs MLTX Comparison
WAFD vs MLTX Comparison
Compare WAFD & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFD
- MLTX
- Stock Information
- Founded
- WAFD 1917
- MLTX 2021
- Country
- WAFD United States
- MLTX Switzerland
- Employees
- WAFD N/A
- MLTX N/A
- Industry
- WAFD Major Banks
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- WAFD Finance
- MLTX Health Care
- Exchange
- WAFD Nasdaq
- MLTX Nasdaq
- Market Cap
- WAFD 2.4B
- MLTX 2.5B
- IPO Year
- WAFD N/A
- MLTX N/A
- Fundamental
- Price
- WAFD $28.19
- MLTX $43.50
- Analyst Decision
- WAFD Hold
- MLTX Strong Buy
- Analyst Count
- WAFD 4
- MLTX 8
- Target Price
- WAFD $30.50
- MLTX $77.71
- AVG Volume (30 Days)
- WAFD 436.6K
- MLTX 676.4K
- Earning Date
- WAFD 07-15-2025
- MLTX 08-06-2025
- Dividend Yield
- WAFD 3.84%
- MLTX N/A
- EPS Growth
- WAFD 1.50
- MLTX N/A
- EPS
- WAFD 2.64
- MLTX N/A
- Revenue
- WAFD $729,805,000.00
- MLTX N/A
- Revenue This Year
- WAFD N/A
- MLTX $103.42
- Revenue Next Year
- WAFD $7.11
- MLTX N/A
- P/E Ratio
- WAFD $10.59
- MLTX N/A
- Revenue Growth
- WAFD 12.73
- MLTX N/A
- 52 Week Low
- WAFD $23.75
- MLTX $31.42
- 52 Week High
- WAFD $38.62
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- WAFD 45.83
- MLTX 52.69
- Support Level
- WAFD $27.45
- MLTX $42.22
- Resistance Level
- WAFD $30.00
- MLTX $44.20
- Average True Range (ATR)
- WAFD 0.59
- MLTX 2.11
- MACD
- WAFD -0.12
- MLTX -0.36
- Stochastic Oscillator
- WAFD 29.02
- MLTX 32.18
About WAFD WaFd Inc.
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.